{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T03:52:30Z","timestamp":1769917950691,"version":"3.49.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T00:00:00Z","timestamp":1304380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/nrneurol.2011.59","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T11:51:55Z","timestamp":1304423515000},"page":"309-310","source":"Crossref","is-referenced-by-count":5,"title":["Assessing the value of plasma exchange in neurology"],"prefix":"10.1038","volume":"7","author":[{"given":"Richard","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Hartung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,3]]},"reference":[{"key":"BFnrneurol201159_CR1","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/S0140-6736(76)91917-6","volume":"2","author":"AJ Pinching","year":"1976","unstructured":"Pinching, A. J., Peters, D. K. & Newsom-Davis, J. Remission of myasthenia gravis following plasma-exchange. Lancet 2, 1373\u20131376 (1976).","journal-title":"Lancet"},{"key":"BFnrneurol201159_CR2","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1212\/WNL.0b013e318207b1f6","volume":"76","author":"I Cortese","year":"2011","unstructured":"Cortese, I.  et al. Evidence-based guideline update: Plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 76, 294\u2013300 (2011).","journal-title":"Neurology"},{"key":"BFnrneurol201159_CR3","doi-asserted-by":"crossref","unstructured":"[No authors listed] Assessment of plasmapheresis. Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 47, 840\u2013843 (1996).","DOI":"10.1212\/WNL.47.3.840"},{"key":"BFnrneurol201159_CR4","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1093\/brain\/119.4.1055","volume":"119","author":"AF Hahn","year":"1996","unstructured":"Hahn, A. F.  et al. Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy. A double-blind, sham-controlled, cross-over study. Brain 119, 1055\u20131066 (1996).","journal-title":"Brain"},{"key":"BFnrneurol201159_CR5","doi-asserted-by":"crossref","unstructured":"Gajdos, P., Chevret, S. & Toyka, K. Plasma exchange for myasthenia gravis. Cochrane Database of Systematic Reviews, Issue 4. Art. No.: CD002275. doi:10.1002\/14651858.CD002275 (2002).","DOI":"10.1002\/14651858.CD002275"},{"key":"BFnrneurol201159_CR6","doi-asserted-by":"crossref","unstructured":"Gajdos, P., Chevret, S. & Toyka, K. Intravenous immunoglobulin for myasthenia gravis. Cochrane Database of Systematic Reviews, Issue 1. Art. No.: CD002277. doi:10.1002\/14651858.CD002277.pub3 (2008).","DOI":"10.1002\/14651858.CD002277.pub3"},{"key":"BFnrneurol201159_CR7","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/ana.22139","volume":"68","author":"A Mandawat","year":"2010","unstructured":"Mandawat, A., Kaminski, H. J., Cutter, G., Katirji, B. & Alshekhlee, A. Comparative analysis of therapeutic options used for myasthenia gravis. Ann. Neurol. 68, 797\u2013805 (2010).","journal-title":"Ann. Neurol."},{"key":"BFnrneurol201159_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1212\/WNL.39.9.1143","volume":"39","author":"HL Weiner","year":"1989","unstructured":"Weiner, H. L.  et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology 39, 1143\u20131149 (1989).","journal-title":"Neurology"},{"key":"BFnrneurol201159_CR9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jneuroim.2010.09.015","volume":"231","author":"HC Lehmann","year":"2010","unstructured":"Lehmann, H. C. & Hartung, H. P. Plasma exchange and intravenous immunoglobulins: mechanism of action in immune-mediated neuropathies. J. Neuroimmunol. 231, 61\u201369 (2010).","journal-title":"J. Neuroimmunol."},{"key":"BFnrneurol201159_CR10","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt, G. H.  et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336, 924\u2013926 (2008).","journal-title":"BMJ"}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.59","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrneurol.2011.59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T05:03:14Z","timestamp":1684472594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrneurol.2011.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,3]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["BFnrneurol201159"],"URL":"https:\/\/doi.org\/10.1038\/nrneurol.2011.59","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,3]]}}}